Insight

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Insight

An update on the development of HER2-targeted therapies

Photo taken from ghealth121.com

Jul 25, 2024, 01:39

An update on the development of HER2-targeted therapies

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:

“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”

HER2-targeted therapies beyond breast cancer – an update | Nature Reviews Clinical Oncology

Autors: Jeesun Yoon and Do-Youn Oh

HER2-targeted

Source: Elisabetta Bonzano/X

Breast Cancer cancer Do-Youn Oh Elisabetta Bonzano HER2-targeted therapy Jeesun Yoon Nature Reviews Clinical Oncology OncoDaily Oncology radiation oncology

Jul 25, 2024, 01:39

An update on the development of HER2-targeted therapies

Jul 25, 2024, 01:28

New Episode of The Cancer Researcher Podcast about becoming a scientific editor

Jul 25, 2024, 01:24

Fred Hutchinson Cancer Center in accepting applications for a strategic leader to head the Sarcoma Program

Jul 25, 2024, 01:14

How cancer cells use antioxidants and how this relates to diseases, including cancer - Wilmot Cancer Institute

Jul 25, 2024, 01:14

Tedros Adhanom Ghebreyesus: New technologies like genomics, AI and big data have the potential to revolutionise the prevention, diagnosis and treatment of disease

Jul 25, 2024, 01:13

Drew Moghanaki: GO2 for Lung Cancer ensuring access to high-quality lung cancer screening for Veterans at risk

Jul 25, 2024, 00:51

STEM Networking night with Yan Leyfman at NSHSS

Jul 25, 2024, 00:46

Fumiko Ladd Chino: Screen for financial toxicity and health-related any social risks

Jul 25, 2024, 00:46

FDA-AACR Oncology Educational Fellowship helped four alumni develop their career trajectories

Jul 25, 2024, 00:44

First-line management of ALK-positive NSCLC with CNS metastases - Florez Lab

Jul 25, 2024, 00:44

Manni Mohyuddin: The results of the GEM-CESAR trial are a stunning verdict against early intervention in SMM

Jul 25, 2024, 00:43

Aaron Tallent: A new standard is poised to transform melanoma care